Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hans Lennart Rudolf Wigzell Insider Profile
11 Followers
Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, holds 22.84K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Hans Lennart Rudolf Wigzell Sold $15,000 shares of Sarepta Therapeutics on Mar 11, 2024 for an estimated value of 1.85M.
Hans Lennart Rudolf Wigzell Sarepta Therapeutics (SRPT)Director
Sarepta Therapeutics (SRPT)
Director
Ranked #42,030 out of 98,564 Corporate Insiders
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
+0.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Hans Lennart Rudolf Wigzell's holdings
Insider Roles
Director
Roles that Hans Lennart Rudolf Wigzell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 11, 2020 - Aug 11, 2021
Return:+48.80%
The most profitable trade made by Hans Lennart Rudolf Wigzell
Hans Lennart Rudolf Wigzell's Trading History
List of latest transactions for each holding click on a transaction to see Hans Lennart Rudolf Wigzell's performance on stock
You May Also Like
Hans Lennart Rudolf Wigzell insider profile FAQ
What is the percentage of profitable transactions made by Hans Lennart Rudolf Wigzell?
The percentage of profitable transactions made by Hans Lennart Rudolf Wigzell is 67%.
What is the average return per transaction made by Hans Lennart Rudolf Wigzell?
The average return per transaction made by Hans Lennart Rudolf Wigzell is 0.80%.
What stocks does Hans Lennart Rudolf Wigzell hold?
Hans Lennart Rudolf Wigzell holds: SRPT stocks.
What was Hans Lennart Rudolf Wigzell’s latest transaction?
Hans Lennart Rudolf Wigzell latest transaction was an Informative Sell of $1.85M.
What was Hans Lennart Rudolf Wigzell's most profitable transaction?
Hans Lennart Rudolf Wigzell’s most profitable transaction was an Informative Sell of SRPT stock on August 11, 2020. The return on the trade was 48.80%.
What is Hans Lennart Rudolf Wigzell's role in Sarepta Therapeutics?
Hans Lennart Rudolf Wigzell's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.